E
ENTX
Entera Bio Ltd
1.220
+0.020+1.67%Closed19:29 06/09 EDT
OPEN/PREV CLOSE1.205/1.200
TODAY RANGE1.180-1.230
VOL25.14K
MARKET CAP60.13M
52 WEEK RANGE0.9100-3.220
AVG VOL (3M)161.17K
% TURNOVER0.05%
TURNOVER0
P/E (TTM)-4.6583
% RANGE4.16%
EPS(TTM)-0.2619
P/E(FORWARD)-3.5882
P/B5.32
BVPS0.2292
DIVIDEND--
P/S1,355.56
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP46.24M
SHARES OUTSTANDING49.29M
NEXT EARNINGS08/06-08/10
FREE FLOAT37.90M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·06/01 13:30
Entera Bio Is Building the Future of Peptides Beyond the Needle (NASDAQ: ENTX)
Seeking Alpha·05/11 06:44
Entera Bio GAAP EPS of -$0.07 beats by $0.02
TipRanks·05/08 22:57
Entera Bio files to sell 19.57M ordinary shares for holders
TipRanks·05/08 20:53
Entera Bio Highlights Q1 2026 Progress and Financing
Dow Jones·04/27 11:53
Entera Bio Price Target Cut to $9.00/Share From $10.00 by HC Wainwright & Co.
Dow Jones·04/27 11:53
Entera Bio Is Maintained at Buy by HC Wainwright & Co.
Benzinga·04/27 11:43
HC Wainwright & Co. Maintains Buy on Entera Bio, Lowers Price Target to $9
TipRanks·04/27 10:12
Entera Bio price target lowered to $9 from $10 at H.C. Wainwright
TipRanks·04/03 21:04
Entera Bio Announces $10 Million Private Placement Financing
Seeking Alpha·04/02 12:59
Entera Bio prices $10M direct investment, sees up to $24.5M in total proceeds
Same Industry
Name/Symbol
Change%
Price